Wellington Management Group’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$368M Sell
4,375,703
-370,882
-8% -$26.9M 0.07% 250
2025
Q4
$358M Buy
4,746,585
+22,884
+0.5% +$1.44M 0.06% 263
2025
Q3
$188M Buy
4,723,701
+917,991
+24% +$35.1M 0.03% 397
2025
Q2
$165M Sell
3,805,710
-1,680,044
-31% -$63.9M 0.03% 396
2025
Q1
$205M Buy
5,485,754
+968,391
+21% +$37.4M 0.04% 341
2024
Q4
$205M Sell
4,517,363
-297,037
-6% -$15.1M 0.04% 363
2024
Q3
$283M Buy
4,814,400
+1,267,451
+36% +$60.7M 0.05% 317
2024
Q2
$140M Buy
3,546,949
+1,277,052
+56% +$62M 0.02% 463
2024
Q1
$151M Buy
2,269,897
+678,419
+43% +$29.6M 0.03% 451
2023
Q4
$44.4M Buy
1,591,478
+4,749
+0.3% +$95.2K 0.01% 743
2023
Q3
$33M Buy
+1,586,729
New +$35M 0.01% 817

Other funds holding APGE